CGNH.US CardioGenics Holdings Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Feb 7, 2026
0.0001 0.0001
Market cap
USD 9.61K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jan 2016.

Is CGNH.US undervalued?

Graham number

The Graham number of CardioGenics Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CardioGenics Holdings Inc fundamental analysis

No fundamental analysis for CardioGenics Holdings Inc yet.

CardioGenics Holdings Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CardioGenics Holdings Inc

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a solid surface in medical laboratories' immunoassay testing equipment. The company w…

Full company profile